Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

AVNS gains on strong SNS and PMR growth, M&A and cost actions, but tariff risks and segment headwinds may weigh on near-term performance.

NEW YORK, March 17, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Avanos Medical, Inc. (NYSE: AVNS) on behalf of the company's shareholders.  The investigation seeks to determine whether Avanos Medical's directors breached their fiduciary duties in connection with recent corporate actions.

Avanos Medical, Inc. (AVNS) Presents at The Citizens Life Sciences Conference 2026 Transcript

ALPHARETTA, Ga., March 2, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dave Pacitti, chief executive officer, and Scott Galovan, senior vice president and chief financial officer, will participate in a fireside chat at the 2026 Citizens Life Sciences Conference on Wed.

Enters into Agreement with Bradley L. Radoff ALPHARETTA, Ga.

AVNS shares plunge 10% even after a Q4 earnings and revenue beat, as margin pressure and tariff concerns weigh on investors.

Avanos Medical, Inc. (AVNS) Q4 2025 Earnings Call Transcript